Sentence examples for monitoring of therapy from inspiring English sources

CA125 is currently the only biomarker recommended for monitoring of therapy as well as detection of recurrence.

Viral load testing for BK Virus (BKV) has become the standard of care for the diagnosis of infection and monitoring of therapy of kidney transplant patients infected with BKV.

Endoscopy can be validated by MRI as a robust methodology for quantitative monitoring of therapy, representing a promising approach for future preclinical efforts to assess utility of novel colorectal cancer prevention strategies.

PET, based on the [18F]FDG method, is of proven usefulness in the diagnosis and monitoring of therapy in patients with lymphoma.

Integrated positron emission tomography and computed tomography (PET/CT) imaging with 18F-fluorodeoxyglucose ([18F]FDG) is increasingly used in patients with HNC for pretreatment staging and monitoring of therapy response [4].

These biomarkers will likely not replace FDG as a first-line imaging approach, but instead offer increased specificity and sensitivity in specific diseases and improved monitoring of therapy response; the choice of biomarker will be guided by personalised assessment of disease that includes genetic factors.

Progress has also been made with regards to the evaluation of biological parameters of the tumour microenvironment (eg, hypoxia) and dynamic monitoring of therapy-induced changes (eg, 5-fluorouracil (5-FU) chemotherapy).

Most FDA cleared tumor markers are for monitoring of therapies (e.g., CA 125 for ovarian cancer and CA 27.29 for breast cancer).

To date DCS has been successfully employed in monitoring of therapies, such as PDT [ 8, 10– 12], chemo-radiation [ 13], and neoadjuvant chemotherapy [ 14].

Molecular imaging with targeted tracers by positron emission tomography (PET) allows for the noninvasive detection and characterization of biological changes at the molecular level, leading to earlier disease detection, objective monitoring of therapies, and better prognostication of cardiovascular diseases progression.

Finding new biomarkers of arthritic diseases and developing novel medical imaging technologies that can assess these biomarkers in living organs become increasingly important for accurate diagnosis and sensitive monitoring of therapies.